Magnocellular neurosecretory cells (MNCs), of the paraventricular and supraoptic nuclei of the hypothalamus, secrete the hormones vasopressin and oxytocin. As a result, they have an essential role in fundamental physiological responses including regulation of blood volume and fluid homeostasis. C-type natriuretic peptide (CNP) is present at high levels in the hypothalamus. Although CNP is known to decrease hormone secretion from MNCs no studies have examined the role of the natriuretic peptide C receptor (NPR-C) in these neurons. In this study, whole-cell recordings from acutely isolated MNCs, and MNCs in a coronal slice preparation, show that CNP (2 x 10 -8 M) and the selective NPR-
Introduction
Since the discovery of atrial natriuretic peptide (ANP) more than twenty years ago (de Bold et al. 1981) , natriuretic peptides have been shown to act as essential regulators of fluid and electrolyte homeostasis in the mammalian central nervous system (Levin et al. 1998) . While three distinct natriuretic peptides, including ANP, brain natriuretic peptide (BNP), and C-type natriuretic peptide (CNP), have been isolated, it is CNP that is most abundant in the mammalian brain (Herman et al. 1993; Kaneko et al. 1993; Ogawa et al. 1992; Yamamoto et al. 1997) . Measurements of immunoreactivity in the area of the hypothalamus indicate CNP expression levels up to 50 times greater than those of ANP or BNP (Herman et al. 1993; Imura et al. 1992) . Furthermore, injection of CNP into the third ventricle of the rat brain potently inhibits the release of vasopressin (VP) (Samson et al. 1991; Shirakami et al. 1993; Yamamoto et al. 1991 ). This effect is two orders of magnitude more potent than that of either ANP or BNP (Yamamoto et al. 1991; Yamamoto et al. 1997) , indicating that CNP is the critical natriuretic peptide modulating MNC excitability.
CNP binds with high affinity to two receptors which have been denoted natriuretic peptide receptor types B and C (NPR-B and NPR-C) (Levin et al. 1998 ). The NPR-B receptor includes an intracellular particulate guanylyl cyclase domain that mediates an increase in intracellular cGMP levels when CNP is bound to it (Lucas et al. 2000) . The NPR-C receptor does not contain a guanylyl cyclase domain and does not alter cGMP levels directly (Levin et al. 1998; Lucas et al. 2000; Maack 1992 ). In the absence of any evidence to the contrary, the inhibitory effect of CNP on hormone release from MNCs in the hypothalamus has been attributed to the NPR-B receptor and a JN-00057-2005 .R2 4 subsequent increase in intracellular cGMP; however, this putative mechanism has not been tested directly (Shirakami et al. 1993; Yamamoto et al. 1997) .
NPR-C is prominently expressed in the mammalian hypothalamus (Peng et al. 1996 ; Sumners and Tang 1992) but it has been largely assigned the role of a 'physiologically silent receptor' in the central nervous system (Imura et al. 1992 ). In the heart and in gastrointestinal smooth muscle, NPR-C has been functionally linked to adenylyl cyclase via a pertussis toxin-sensitive G protein (Anand-Srivastava et al. 1996; Anand-Srivastava and Cantin 1986; Murthy and Makhlouf 1999; Murthy et al. 2000) .
NPR-C receptors, which are disulfide-linked homodimers with a single transmembrane domain (Anand-Srivastava and Trachte 1993) contain a specific G i -activator domain within the intracellular portion of the receptor, a motif that was first described for the insulin-like growth factor receptor (Okamoto et al. 1990 ). In NPR-C, it is a 17 amino acid sequence (R 469 -R 485 ) within in the 37 amino acid intracellular domain that is responsible for the activation of G i (Pagano and Anand-Srivastava 2001; Zhou and Murthy 2003) . In this way, natriuretic peptides, when bound to NPR-C, are able to activate G i proteins and decrease cAMP levels via the inhibition of adenylyl cyclase (Anand-Srivastava et al. 1996; Pagano and Anand-Srivastava 2001) . We have recently demonstrated that CNP has a potent and selective inhibitory effect on L-type calcium channels (I Ca(L) ) in the heart. This effect is mediated by this NPR-C/G i signaling pathway (Rose et al. 2003; Rose et al. 2004a ). 
Methods

Isolation of magnocellular neurosecretory cells
MNCs were isolated enzymatically from the supraoptic nucleus (SON) of the rat as described previously (Oliet and Bourque 1992) . In summary, male Sprague Dawley rats (75-125 g) were decapitated and their brains were removed from the cranial vault. A coronal brain slice approximately 2-3 mm in thickness was cut using a razor blade and two blocks of tissue containing the SON were dissected out of this slice. These tissue blocks were incubated for 90 min at 34-35°C in 10 ml of oxygenated (100% O 2 ) PIPES saline containing 7 mg of trypsin (Sigma type XI). PIPES saline consisted of (in mM) JN-00057-2005.R2 6 25 glucose, pH was adjusted to 7. After enzyme treatment the tissue blocks were rinsed twice with trypsin-free PIPES saline and then triturated with fire polished pipettes (0.2-0.5 mm inner diameter) to disperse the cells. The cell suspension was then plated onto recording dishes for electrophysiological recordings.
Brain slice preparation
Coronal brain slices through the hypothalamus and containing the paraventricular nucleus (PVN) were prepared from male Sprague Dawley rats (75-125 g) as described previously (Gordon and Bains 2003) . Rats were anesthetized with sodium pentobarbitol (3 mg/kg), decapitated, and the brains were excised into ice-cold high-sucrose slicing solution composed of (in mM) 87 NaCl, 2.5 KCl, 25 NaHCO 3 , 0.5 CaCl 2 , 7 MgCl 2 , 1.25
NaH 2 PO 4 , 25 glucose, 75 sucrose, 3 pyruvic acid, 1 ascorbic acid saturated with carbogen gas (95% O 2 , 5% CO 2 ). The brain was blocked and mounted on a vibrating slicer (Leica) with the tissue submerged in slicing solution for the duration of the slicing procedure.
The hypothalamus was sliced in the coronal plane and each slice (300 µM in thickness)
was further hemisected and incubated in artificial cerebrospinal fluid (ACSF) composed of (in mM) 126 NaCl, 2.5 KCl, 26 NaHCO 3 , 2 CaCl 2 , 2 MgCl 2 , 1.25 NaH 2 PO 4 , 10 glucose, 1 ascorbic acid, saturated with carbogen gas and maintained at 32.5°C.
Hypothalamic slices were incubated for approximately 60 min before any electrophysiological recordings were made. All tissue preparations and animal handling procedures were in accordance with the guidelines set out by the University of Calgary animal care facility. 
Statistical analysis
Summary data are presented as means ± SE. The data were analyzed using an ANOVA with Dunnett's multiple comparison procedure (in most cases) or a paired Student's t-test ( Fig. 8 and Table 1 ) to identify significant differences. In all cases, a p value less than 0.05 was considered significant.
Results
Identification of calcium currents in MNCs
Initial experiments sought to confirm previous work that identifies specific voltage gated calcium currents in the somata of MNCs ( was approximately -14 pA/pF in both recordings. On average, I Ca(L) was stable with current densities of -15 to -20 pA/pF over 300 s (mean ± SE; n = 6 MNCs). These recordings ( Fig. 1D ) demonstrate that I Ca(L) can be recorded in isolated MNCs for more than 5 min without a significant change in current magnitude. Figure 
Effect of CNP on I Ca(L) in isolated MNCs
To explore the electrophysiological effects of CNP on MNCs, voltage clamp measurements of I Ca(L) were made on enzymatically isolated MNCs. Figures 2A and 2B illustrate the effect of CNP (2 x 10 -8 M) on peak I Ca(L) measured during a 250 ms voltage clamp step to 0 mV, following a pre-pulse to -40 mV for 250 ms. This CNP dose is near the EC 50 value for CNP effects evaluated in biochemical studies of natriuretic peptide signaling (Anand-Srivastava et al. 1990; Anand-Srivastava et al. 1996) and also within the range of natriuretic peptide doses shown to inhibit hormone release from MNCs in the hypothalamus (Yamamoto et al. 1991; Yamamoto et al. 1997) . Therefore, this CNP dose is used throughout this study. Sample recordings ( Fig (Fig. 2D) shows that, on average, cANF decreased peak I Ca(L) from -27.7 ± 7.7 to -12.4 ± 3.6 pA/pF (n = 6 neurons; p < 0.05).
I Ca(L) was stable at this reduced amplitude for up to 30 min of washout. Partial recovery of I Ca(L) current magnitude could be observed when the peptide was washed for longer than 30 min (data not shown).
Effect of CNP is occluded by nicardipine
In order to determine if the NPR-C-mediated effect on CNP was specific to I Ca(L) we performed an occlusion experiment in which nicardipine (1 x 10 -5 M) was applied to 
Effects of CNP on I Ca(L) in MNCs in situ
We next examined the effects of CNP on MNCs in an acutely prepared hypothalamic In this MNC, I Ca(L) was reduced from -20 to -4 pA/pF over the course of 300s following the application of CNP (2 x 10 -8 M). The summary IV curve, which is illustrated in Fig.   3C , shows that on average CNP reduced peak I Ca(L) in MNCs from -27.4 ± 2.3 to -15.6 ± 2.3 pA/pF (n = 8 neurons; p < 0.05). 
CNP does not affect I Ca(T)
As illustrated in Fig. 1 , and by others (Fisher and Bourque 1995; Fisher and Bourque 1996) , the somata of MNCs also express T-type Ca 2+ channels. The effects of the NPR-C agonist, cANF (2 x 10 -8 M), on I Ca(T) , which was measured during a voltage clamp step to -40 mV for 250 ms in the presence of TTX (1 x 10 -6 M), are illustrated in in all treatment groups we suggest that this 10-15% reduction is likely a small run-down of the current over time rather than a specific effect of CNP. Fisher and Bourque 1996), the experiment presented in Fig. 3 , in which the effect of cANF on I Ca(L) was occluded by nicardipine, indicates that the NPR-C-mediated effect of 1995; Fisher and Bourque 1996) . Therefore, it may be that nicardipine blocks the majority of I Ca(L) and that the current remaining during our voltage clamp protocol is a different high voltage activated Ca 2+ conductance. In this case, because the effects of CNP are completely occluded by nicardipine (Fig. 3) , CNP would be inhibiting I Ca(L) by much more than 50% at the dose used in this study.
Effect of CNP on action potential firing and action potential duration
In the heart the NPR-C receptor is known to inhibit adenylyl cyclase via the activation of a pertussis toxin-sensitive G i protein (Anand-Srivastava and Cantin 1986; Anand-Srivastava et al. 1987; Anand-Srivastava et al. 1996) . This occurs through a 
1997).
Effects of CNP on MNC excitability
We have shown that CNP and the NPR-C agonist, cANF, significantly inhibit action potential firing and APD 50 in MNCs in an in situ hypothalamic slice preparation. It is important to note that cANF has no capacity to activate the NPR-B-cGMP pathway. 
